186 related articles for article (PubMed ID: 7474675)
21. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.
Hall WD; Kusek JW; Kirk KA; Appel LJ; Schulman G; Agodoa LY; Glassock R; Grim C; Randall OS; Massry SG
Am J Kidney Dis; 1997 May; 29(5):720-8. PubMed ID: 9159306
[TBL] [Abstract][Full Text] [Related]
22. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
[TBL] [Abstract][Full Text] [Related]
23. Net endogenous acid production is associated with a faster decline in GFR in African Americans.
Scialla JJ; Appel LJ; Astor BC; Miller ER; Beddhu S; Woodward M; Parekh RS; Anderson CA;
Kidney Int; 2012 Jul; 82(1):106-12. PubMed ID: 22475819
[TBL] [Abstract][Full Text] [Related]
24. ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.
Segura J; Campo C; Rodicio JL; Ruilope LM
Hypertension; 2001 Sep; 38(3 Pt 2):645-9. PubMed ID: 11566948
[TBL] [Abstract][Full Text] [Related]
25. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension.
Regalado M; Yang S; Wesson DE
Am J Kidney Dis; 2000 Apr; 35(4):687-94. PubMed ID: 10739791
[TBL] [Abstract][Full Text] [Related]
26. The link between hypertension and nephrosclerosis.
Freedman BI; Iskandar SS; Appel RG
Am J Kidney Dis; 1995 Feb; 25(2):207-21. PubMed ID: 7847347
[TBL] [Abstract][Full Text] [Related]
27. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease.
Norris KC; Greene T; Kopple J; Lea J; Lewis J; Lipkowitz M; Miller P; Richardson A; Rostand S; Wang X; Appel LJ
J Am Soc Nephrol; 2006 Oct; 17(10):2928-36. PubMed ID: 16959828
[TBL] [Abstract][Full Text] [Related]
28. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
Toto RD
Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
[TBL] [Abstract][Full Text] [Related]
29. Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis.
Fung MM; Chen Y; Lipkowitz MS; Salem RM; Bhatnagar V; Mahata M; Nievergelt CM; Rao F; Mahata SK; Schork NJ; Brophy VH; O'Connor DT;
Nephrol Dial Transplant; 2009 Dec; 24(12):3677-86. PubMed ID: 19745105
[TBL] [Abstract][Full Text] [Related]
30. Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.
Hsu CY; Huang PH; Chen TH; Chiang CH; Leu HB; Huang CC; Chen JW; Lin SJ
Am J Hypertens; 2016 Apr; 29(4):528-36. PubMed ID: 26298010
[TBL] [Abstract][Full Text] [Related]
31. Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).
Fung MM; Salem RM; Lipkowitz MS; Bhatnagar V; Pandey B; Schork NJ; O'Connor DT;
Nephrol Dial Transplant; 2012 Jan; 27(1):197-205. PubMed ID: 21613384
[TBL] [Abstract][Full Text] [Related]
32. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
[TBL] [Abstract][Full Text] [Related]
33. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
[TBL] [Abstract][Full Text] [Related]
34. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
35. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
36. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
[TBL] [Abstract][Full Text] [Related]
37. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
38. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
[TBL] [Abstract][Full Text] [Related]
39. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
40. Enalapril versus metoprolol in primary hypertension--effects on the glomerular filtration rate.
Aurell M; Bengtsson C; Björck S
Nephrol Dial Transplant; 1997 Nov; 12(11):2289-94. PubMed ID: 9394313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
